Skip to main content

Table 3 Effect of test items on uterus weight, on uterine glycogen levels, and on serum lipid profile

From: Identification of validated substitute for Asoka (Saraca asoca (Roxb.) Willd.) by phytochemical and pharmacological evaluations

TreatmentOrgan weights (g)Uterine glycogen level (%w/w)Lipid profile
UterusTotal cholesterol (mg/dl)Triglycerides (mg/dl)HDL (mg/dl)
G1: Normal0.91 ± 0.330.52 ± 0.11100.20 ± 10.3881.67 ± 7.9444.67 ± 8.95
G2: Control0.34 ± 0.05#0.38 ± 0.05#156.50 ± 11.15#121.20 ± 18.06#25.50 ± 5.61#
G3: AB (200 mg/kg, p.o.)0.80 ± 0.20*0.45 ± 0.08136.50 ± 12.6584.50 ± 14.79*35.17 ± 3.86
G4:AB (400 mg/kg, p.o.)1.02 ± 0.14*0.50 ± 0.0998.83 ± 14.08*79.17 ± 11.00*44.50 ± 7.23*
G5: AS (200 mg/kg, p.o.)0.36 ± 0.080.26 ± 0.05143.30 ± 14.18111.70 ± 8.4028.17 ± 5.84
G6: AS (400 mg/kg, p.o.)0.99 ± 0.11*0.29 ± 0.06109.20 ± 13.18*101.30 ± 9.15*41.67 ± 6.71*
G7: PB (200 mg/kg, p.o.)0.44 ± 0.140.36 ± 0.06151.00 ± 16.67106.00 ± 8.0226.00 ± 8.36
G8: PB (200 mg/kg, p.o.)0.53 ± 0.140.32 ± 0.04137.70 ± 14.62106.50 ± 13.5525.50 ± 5.54
G9: SB (200 mg/kg, p.o.)0.83 ± 0.17*0.30 ± 0.09113.20 ± 18.12*92.83 ± 10.80*36.83 ± 6.73
G10: SB (400 mg/kg, p.o.)1.00 ± 0.09*0.32 ± 0.06102.70 ± 14.61*82.17 ± 8.65*40.50 ± 9.00*
G11: TB (200 mg/kg, p.o.)0.47 ± 0.120.32 ± 0.07149.20 ± 10.57104.80 ± 10.2528.67 ± 10.27
G12: TB (200 mg/kg, p.o.)0.59 ± 0.120.34 ± 0.05153.00 ± 8.19107.00 ± 10.3525.00 ± 6.54
  1. Values are mean ± SD, n = 6, #p < 0.05 when compared to GP1 normal and *p < 0.05 when compared to GP-2 control by ANOVA followed by Dunnett’s post-test